Skip to main content
Top
Published in: BMC Cardiovascular Disorders 1/2024

Open Access 02-03-2024 | Cardiomyopathy | Case Report

Is Takotsubo syndrome induced by patent ductus arteriosus occlusion?

Authors: Shuhao Li, Senyan Yang, Shujing Zhou, Shuang Zhang, Xueying Li, Haibo Zhang, Ping Ren, Yanwu Liu, Ying Liu, Yuanguo Chen

Published in: BMC Cardiovascular Disorders | Issue 1/2024

Login to get access

Abstract

Takotsubo syndrome (TTS), commonly referred to as "broken heart syndrome," is a distinctive form of acute and reversible heart failure that primarily affects young to middle-aged individuals, particularly women. While emotional or physical stressors often trigger TTS, rare cases have been linked to interventional procedures for congenital heart disease (CHD). Despite its recognition, the exact causes of TTS remain elusive. Research indicates that dysregulation in autonomic nerve function, involving sympathetic and parasympathetic activities, plays a pivotal role. Genetic factors, hormonal influences like estrogen, and inflammatory processes also contribute, unveiling potential gender-specific differences in its occurrence. Understanding these multifaceted aspects of TTS is crucial for refining clinical approaches and therapies. Continued research efforts will not only deepen our understanding of this syndrome but also pave the way for more targeted and effective diagnostic and treatment strategies. In this report, we conduct an in-depth analysis of a case involving a TTS patient, examining the illness progression and treatment procedures. The aim of this analysis is to enhance the understanding of TTS among primary care physicians. By delving into this case, we aspire to prevent misdiagnosis of typical TTS cases that patients may present, thereby ensuring a more accurate diagnosis and appropriate treatment.
Appendix
Available only for authorised users
Literature
1.
go back to reference Rotondi FM, Manganelli F. Takotsubo cardiomyopathy and arrhythmic risk: the dark side of the moon. Eur Rev Med Pharmacol Sci. 2013;17(1):105–11.PubMed Rotondi FM, Manganelli F. Takotsubo cardiomyopathy and arrhythmic risk: the dark side of the moon. Eur Rev Med Pharmacol Sci. 2013;17(1):105–11.PubMed
2.
go back to reference Akhtar MM, Cammann VL, Templin C, Ghadri JR, Lüscher TF. Takotsubo syndrome: getting closer to its causes. Cardiovasc Res. 2023;119(7):1480–94.CrossRefPubMed Akhtar MM, Cammann VL, Templin C, Ghadri JR, Lüscher TF. Takotsubo syndrome: getting closer to its causes. Cardiovasc Res. 2023;119(7):1480–94.CrossRefPubMed
3.
go back to reference Lyon AR, Citro R, Schneider B, Morel O, Ghadri JR, Templin C, et al. Pathophysiology of Takotsubo Syndrome. J Am Coll Cardiol. 2021;77(7):902–21.CrossRefPubMed Lyon AR, Citro R, Schneider B, Morel O, Ghadri JR, Templin C, et al. Pathophysiology of Takotsubo Syndrome. J Am Coll Cardiol. 2021;77(7):902–21.CrossRefPubMed
4.
go back to reference Ghadri J-R, Wittstein IS, Prasad A, Sharkey S, Dote K, Akashi YJ, et al. International Expert Consensus Document on Takotsubo Syndrome (Part I): Clinical Characteristics, Diagnostic Criteria, and Pathophysiology. Eur Heart J. 2018;39(22):2032–46.CrossRefPubMedPubMedCentral Ghadri J-R, Wittstein IS, Prasad A, Sharkey S, Dote K, Akashi YJ, et al. International Expert Consensus Document on Takotsubo Syndrome (Part I): Clinical Characteristics, Diagnostic Criteria, and Pathophysiology. Eur Heart J. 2018;39(22):2032–46.CrossRefPubMedPubMedCentral
5.
go back to reference Lüscher TF, Akhtar MM. Correction to: Looking deeper into takotsubo heart. Cardiovascular Research. 2022;118(8):2033.CrossRefPubMed Lüscher TF, Akhtar MM. Correction to: Looking deeper into takotsubo heart. Cardiovascular Research. 2022;118(8):2033.CrossRefPubMed
8.
go back to reference Abdullah I. Takotsubo syndrome spreads its tentacles to congenital heart disease. J Thorac Cardiovasc Surg. 2017;154(6):e111. Abdullah I. Takotsubo syndrome spreads its tentacles to congenital heart disease. J Thorac Cardiovasc Surg. 2017;154(6):e111.
9.
go back to reference Akazawa Y, Higaki T, Higashi H, Yamaguchi O, Pellicori P. Takotsubo syndrome following patent ductus arteriosus device closure. Eur Heart J Case Rep. 2022;6:1-2. Akazawa Y, Higaki T, Higashi H, Yamaguchi O, Pellicori P. Takotsubo syndrome following patent ductus arteriosus device closure. Eur Heart J Case Rep. 2022;6:1-2.
10.
go back to reference Silverio A, Parodi GA-O, Scudiero F, Bossone E, Di Maio M, Vriz OA-O, et al. Beta-blockers are associated with better long-term survival in patients with Takotsubo syndrome. Heart. 2022;108(17):1369–76.CrossRefPubMed Silverio A, Parodi GA-O, Scudiero F, Bossone E, Di Maio M, Vriz OA-O, et al. Beta-blockers are associated with better long-term survival in patients with Takotsubo syndrome. Heart. 2022;108(17):1369–76.CrossRefPubMed
11.
go back to reference Couch LS, Channon K, Thum T. Molecular Mechanisms of Takotsubo Syndrome. Int J Mol Sci. 2022;23(20):12262. Couch LS, Channon K, Thum T. Molecular Mechanisms of Takotsubo Syndrome. Int J Mol Sci. 2022;23(20):12262.
12.
go back to reference Kato K, Lyon AR, Ghadri J-R, Templin C. Takotsubo syndrome: aetiology, presentation and treatment. Heart. 2017;103(18):1461–9.CrossRefPubMed Kato K, Lyon AR, Ghadri J-R, Templin C. Takotsubo syndrome: aetiology, presentation and treatment. Heart. 2017;103(18):1461–9.CrossRefPubMed
13.
go back to reference Singh T, Khan H, Gamble DT, Scally C, Newby DE, Dawson D. Takotsubo Syndrome: Pathophysiology, Emerging Concepts, and Clinical Implications. Circulation. 2022;145(13):1002–19.CrossRefPubMedPubMedCentral Singh T, Khan H, Gamble DT, Scally C, Newby DE, Dawson D. Takotsubo Syndrome: Pathophysiology, Emerging Concepts, and Clinical Implications. Circulation. 2022;145(13):1002–19.CrossRefPubMedPubMedCentral
14.
go back to reference Nour A, Abdelrazik Y, Huessin S, Kamel H. Safety and efficacy of percutaneous patent ductus arteriosus closure: a multicenter Egyptian experience. Egypt Heart J. 2022;74(1):14. Nour A, Abdelrazik Y, Huessin S, Kamel H. Safety and efficacy of percutaneous patent ductus arteriosus closure: a multicenter Egyptian experience. Egypt Heart J. 2022;74(1):14.
15.
go back to reference Baker C, Muse J, Taussky P. Takotsubo Syndrome in Neurologic Disease. World Neurosurg. 2021;149(1878–8769 (Electronic)):26–31.CrossRefPubMed Baker C, Muse J, Taussky P. Takotsubo Syndrome in Neurologic Disease. World Neurosurg. 2021;149(1878–8769 (Electronic)):26–31.CrossRefPubMed
16.
go back to reference Hurst RT, Prasad A, Askew JW, Sengupta PP, Tajik AJ. Takotsubo Cardiomyopathy: A Unique Cardiomyopathy With Variable Ventricular Morphology. JACC:Cardiovascular Imaging. 2010;3(6):641–9.PubMed Hurst RT, Prasad A, Askew JW, Sengupta PP, Tajik AJ. Takotsubo Cardiomyopathy: A Unique Cardiomyopathy With Variable Ventricular Morphology. JACC:Cardiovascular Imaging. 2010;3(6):641–9.PubMed
Metadata
Title
Is Takotsubo syndrome induced by patent ductus arteriosus occlusion?
Authors
Shuhao Li
Senyan Yang
Shujing Zhou
Shuang Zhang
Xueying Li
Haibo Zhang
Ping Ren
Yanwu Liu
Ying Liu
Yuanguo Chen
Publication date
02-03-2024

Other articles of this Issue 1/2024

BMC Cardiovascular Disorders 1/2024 Go to the issue